Somaxon Pharmaceutical buy phonebroker
Start price
01.09.10
/
50%
€24.00
Target price
02.09.10
€32.00
Performance (%)
0.00%
End price
02.09.10
€24.00
Summary
This prediction ended on 02.09.10 with a price of €24.00. The BUY prediction by phonebroker closed unchanged from the start price. phonebroker has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Somaxon Pharmaceutical | - | - | - | - |
| iShares Core DAX® | 1.717% | 3.368% | 5.887% | 52.377% |
| iShares Nasdaq 100 | -4.565% | -4.238% | 21.386% | 72.449% |
| iShares Nikkei 225® | -7.120% | -11.869% | 42.357% | 57.579% |
| iShares S&P 500 | -0.894% | 1.687% | 19.495% | 62.154% |
Comments by phonebroker for this prediction
In the thread Somaxon Pharmaceutical diskutieren
kaufen
Die Kaufempfehlung stützt sich auf folgede positive Nachricht.
Somaxon Pharmaceuticals landing Procter & Gamble as a marketing partner for the commercial launch of Somaxon's new sleeping pill Silenor.
(Stop Loss Kurs erreicht)